Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
15 hedge funds and large institutions have $294K invested in Biocept, Inc. in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
15% more funds holding
Funds holding: 13 → 15 (+2)
3% less capital invested
Capital invested by funds: $302K → $294K (-$8.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$263K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$59.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$22.4K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$21.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$17.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$24K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13K |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$8K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
BIOC Hedge Fund Activity: Q4 2019 in Review
15 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2019, worth a combined $294K — down 2.7% from $302K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BIOC positions and 5 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $263K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $24K sold.
- 15 institutional investors held Biocept, Inc. (BIOC) as of Q4 2019, up from 13 in Q3 2019.
- Funds reported $294K of Biocept, Inc. stock for Q4 2019, down 2.7% quarter-over-quarter.
- 7 funds opened new Biocept, Inc. positions in Q4 2019 and 5 closed out, a net change of +2 holders.
- The largest Biocept, Inc. buyer in Q4 2019 was Renaissance Technologies, an estimated $263K added.
- The largest Biocept, Inc. seller in Q4 2019 was A.R.T. Advisors, an estimated $24K sold.
Based on aggregated 13F filings for Q4 2019.